FDA Planning Disease-Specific Guidances and Endpoints for New Gene Therapies

The FDA is planning to deliver a suite of disease-specific guidance documents next year on developing targeted gene therapies, starting with hemophilia and then more common single-gene disorders, Commissioner Scott Gottlieb told senators Thursday.
Source: Drug Industry Daily